Shree Pushkar Chemicals & Fertilizers Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: September 6, 2025, 7:24 am

Quick Insight

Shree Pushkar Chemicals & Fertilizers Ltd, with a current share price of 320, a market capitalization of 1,034 Cr., and a P/E ratio of 15.5, presents an intriguing investment opportunity in the Chemicals industry. With a respectable ROE and ROCE of 11.6% and 11.8% respectively, coupled with an OPM of 11%, the company demonstrates solid financial performance. However, the absence of significant institutional ownership and detailed shareholder information raises transparency concerns. The healthy ICR of 41.38x and manageable CCC of 81 days indicate efficient operations and liquidity management. Investors should closely monitor developments in promoter holdings and institutional interest to gauge future growth prospects.

Competitors of Shree Pushkar Chemicals & Fertilizers Ltd

All Competitor Stocks of Shree Pushkar Chemicals & Fertilizers Ltd

Quarterly Result

Last Updated: August 20, 2025, 3:45 am

Below is a detailed analysis of the quarterly data for Shree Pushkar Chemicals & Fertilizers Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 255.00 Cr.. The value appears strong and on an upward trend. It has increased from 219.00 Cr. (Mar 2025) to 255.00 Cr., marking an increase of 36.00 Cr..
• For Expenses, as of Jun 2025, the value is 225.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 195.00 Cr. (Mar 2025) to 225.00 Cr., marking an increase of 30.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 29.00 Cr.. The value appears strong and on an upward trend. It has increased from 25.00 Cr. (Mar 2025) to 29.00 Cr., marking an increase of 4.00 Cr..
• For OPM %, as of Jun 2025, the value is 11.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 11.00%.
• For Other Income, as of Jun 2025, the value is 4.00 Cr.. The value appears strong and on an upward trend. It has increased from 2.00 Cr. (Mar 2025) to 4.00 Cr., marking an increase of 2.00 Cr..
• For Interest, as of Jun 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 1.00 Cr..
• For Depreciation, as of Jun 2025, the value is 6.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 6.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 26.00 Cr.. The value appears strong and on an upward trend. It has increased from 20.00 Cr. (Mar 2025) to 26.00 Cr., marking an increase of 6.00 Cr..
• For Tax %, as of Jun 2025, the value is 19.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 19.00%.
• For Net Profit, as of Jun 2025, the value is 21.00 Cr.. The value appears strong and on an upward trend. It has increased from 17.00 Cr. (Mar 2025) to 21.00 Cr., marking an increase of 4.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 6.48. The value appears strong and on an upward trend. It has increased from 5.11 (Mar 2025) to 6.48, marking an increase of 1.37.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: August 23, 2025, 2:05 pm

Growth

Last Updated: September 5, 2025, 1:26 pm

Balance Sheet

Last Updated: June 16, 2025, 11:22 am

Below is a detailed analysis of the balance sheet data for Shree Pushkar Chemicals & Fertilizers Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 32.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 32.00 Cr..
• For Reserves, as of Mar 2025, the value is 507.00 Cr.. The value appears strong and on an upward trend. It has increased from 442.00 Cr. (Mar 2024) to 507.00 Cr., marking an increase of 65.00 Cr..
• For Borrowings, as of Mar 2025, the value is 101.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 108.00 Cr. (Mar 2024) to 101.00 Cr., marking a decrease of 7.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 227.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 128.00 Cr. (Mar 2024) to 227.00 Cr., marking an increase of 99.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 867.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 710.00 Cr. (Mar 2024) to 867.00 Cr., marking an increase of 157.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 308.00 Cr.. The value appears strong and on an upward trend. It has increased from 295.00 Cr. (Mar 2024) to 308.00 Cr., marking an increase of 13.00 Cr..
• For CWIP, as of Mar 2025, the value is 54.00 Cr.. The value appears strong and on an upward trend. It has increased from 42.00 Cr. (Mar 2024) to 54.00 Cr., marking an increase of 12.00 Cr..
• For Investments, as of Mar 2025, the value is 94.00 Cr.. The value appears to be declining and may need further review. It has decreased from 118.00 Cr. (Mar 2024) to 94.00 Cr., marking a decrease of 24.00 Cr..
• For Other Assets, as of Mar 2025, the value is 411.00 Cr.. The value appears strong and on an upward trend. It has increased from 254.00 Cr. (Mar 2024) to 411.00 Cr., marking an increase of 157.00 Cr..
• For Total Assets, as of Mar 2025, the value is 867.00 Cr.. The value appears strong and on an upward trend. It has increased from 710.00 Cr. (Mar 2024) to 867.00 Cr., marking an increase of 157.00 Cr..

Notably, the Reserves (507.00 Cr.) exceed the Borrowings (101.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Shree Pushkar Chemicals & Fertilizers Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 18.25. This value is within the healthy range. It has increased from 11.72 (Mar 24) to 18.25, marking an increase of 6.53.
• For Diluted EPS (Rs.), as of Mar 25, the value is 18.22. This value is within the healthy range. It has increased from 11.69 (Mar 24) to 18.22, marking an increase of 6.53.
• For Cash EPS (Rs.), as of Mar 25, the value is 25.13. This value is within the healthy range. It has increased from 18.55 (Mar 24) to 25.13, marking an increase of 6.58.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 166.64. It has increased from 149.75 (Mar 24) to 166.64, marking an increase of 16.89.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 166.64. It has increased from 149.75 (Mar 24) to 166.64, marking an increase of 16.89.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 249.33. It has increased from 229.61 (Mar 24) to 249.33, marking an increase of 19.72.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 29.27. This value is within the healthy range. It has increased from 22.58 (Mar 24) to 29.27, marking an increase of 6.69.
• For PBIT / Share (Rs.), as of Mar 25, the value is 22.27. This value is within the healthy range. It has increased from 15.75 (Mar 24) to 22.27, marking an increase of 6.52.
• For PBT / Share (Rs.), as of Mar 25, the value is 21.56. This value is within the healthy range. It has increased from 15.25 (Mar 24) to 21.56, marking an increase of 6.31.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 18.13. This value is within the healthy range. It has increased from 11.72 (Mar 24) to 18.13, marking an increase of 6.41.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 18.13. This value is within the healthy range. It has increased from 11.72 (Mar 24) to 18.13, marking an increase of 6.41.
• For PBDIT Margin (%), as of Mar 25, the value is 11.74. This value is within the healthy range. It has increased from 9.83 (Mar 24) to 11.74, marking an increase of 1.91.
• For PBIT Margin (%), as of Mar 25, the value is 8.93. This value is below the healthy minimum of 10. It has increased from 6.85 (Mar 24) to 8.93, marking an increase of 2.08.
• For PBT Margin (%), as of Mar 25, the value is 8.64. This value is below the healthy minimum of 10. It has increased from 6.64 (Mar 24) to 8.64, marking an increase of 2.00.
• For Net Profit Margin (%), as of Mar 25, the value is 7.27. This value is within the healthy range. It has increased from 5.10 (Mar 24) to 7.27, marking an increase of 2.17.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 7.27. This value is below the healthy minimum of 8. It has increased from 5.10 (Mar 24) to 7.27, marking an increase of 2.17.
• For Return on Networth / Equity (%), as of Mar 25, the value is 10.87. This value is below the healthy minimum of 15. It has increased from 7.82 (Mar 24) to 10.87, marking an increase of 3.05.
• For Return on Capital Employeed (%), as of Mar 25, the value is 12.34. This value is within the healthy range. It has increased from 9.68 (Mar 24) to 12.34, marking an increase of 2.66.
• For Return On Assets (%), as of Mar 25, the value is 6.76. This value is within the healthy range. It has increased from 5.22 (Mar 24) to 6.76, marking an increase of 1.54.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.18. This value is within the healthy range. It has decreased from 0.22 (Mar 24) to 0.18, marking a decrease of 0.04.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.02. It has decreased from 1.06 (Mar 24) to 1.02, marking a decrease of 0.04.
• For Current Ratio (X), as of Mar 25, the value is 1.67. This value is within the healthy range. It has decreased from 1.80 (Mar 24) to 1.67, marking a decrease of 0.13.
• For Quick Ratio (X), as of Mar 25, the value is 1.10. This value is within the healthy range. It has decreased from 1.48 (Mar 24) to 1.10, marking a decrease of 0.38.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 5.00. This value is within the healthy range. It has decreased from 6.37 (Mar 24) to 5.00, marking a decrease of 1.37.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 41.38. This value is within the healthy range. It has decreased from 45.72 (Mar 24) to 41.38, marking a decrease of 4.34.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 26.62. This value is within the healthy range. It has increased from 24.72 (Mar 24) to 26.62, marking an increase of 1.90.
• For Enterprise Value (Cr.), as of Mar 25, the value is 935.74. It has increased from 610.81 (Mar 24) to 935.74, marking an increase of 324.93.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.16. This value is within the healthy range. It has increased from 0.84 (Mar 24) to 1.16, marking an increase of 0.32.
• For EV / EBITDA (X), as of Mar 25, the value is 9.88. This value is within the healthy range. It has increased from 8.55 (Mar 24) to 9.88, marking an increase of 1.33.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.07. This value is within the healthy range. It has increased from 0.69 (Mar 24) to 1.07, marking an increase of 0.38.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Price / BV (X), as of Mar 25, the value is 1.60. This value is within the healthy range. It has increased from 1.06 (Mar 24) to 1.60, marking an increase of 0.54.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.07. This value is within the healthy range. It has increased from 0.69 (Mar 24) to 1.07, marking an increase of 0.38.
• For EarningsYield, as of Mar 25, the value is 0.06. This value is below the healthy minimum of 5. It has decreased from 0.07 (Mar 24) to 0.06, marking a decrease of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness